Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,598,210
-
Share change
-
+43,694
-
Total reported value
-
$2,219,249
-
Price per share
-
$1.39
-
Number of holders
-
23
-
Value change
-
+$62,237
-
Number of buys
-
10
-
Number of sells
-
8
Institutional Holders of ACER THERAPEUTICS INC - COM (ACER) as of Q3 2022
As of 30 Sep 2022,
ACER THERAPEUTICS INC - COM (ACER) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,598,210 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, Copperwynd Financial, LLC, NORTHERN TRUST CORP, and STATE STREET CORP.
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.